We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

Roche revealed in its first-quarter results statement ... start to the year with a 6% gain to CHF 11.2 billion. Ocrevus rose 18% to CHF 1.4 billion, while Hemlibra was up 30% to CHF 853 million.

We know rhythm, even before we know our own voice,” says Gino Banks, as he picks up this writer’s call in the middle of a shoot. The drummer is in the middle of preparations for his annual ...

SHOPPING: Achieve your body goals - and FINALLY lose those extra pounds with this delicious shake available in mouth-watering flavors and packed with 29 grams of protein. SHOPPING: Restore your ...

Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, and announced a dividend and stock buyback program ...